Sfoglia per ???browse.type.metadata.subjectIsicrui???
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype
2011-12-01 Malet, I; Fourati, S; Charpentier, C; Morand Joubert, L; Armenia, D; Wirden, M; Sayon, S; Van Houtte, M; CECCHERINI SILBERSTEIN, F; Brun Vézinet, F; Perno, Cf; Descamps, D; Capt, A; Calvez, V; Marcelin, A
The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs
2005-04-25 Auwerx, J; Van Nieuwenhove, J; Rodríguez Barrios, F; de Castro, S; Velázquez, S; CECCHERINI SILBERSTEIN, F; De Clercq, E; Camarasa, M; Perno, Cf; Gago, F; Balzarini, J
The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs
2005-01-01 Auwerx, J; Van Nieuwenhove, J; Rodriguez Barrios, F; De Castro, S; Velazquez, S; CECCHERINI SILBERSTEIN, F; De Clercq, E; Camarasa, M; Perno, Cf; Gago, F; Balzarini, J
The novel KI, WU, MC polyomaviruses: possible human pathogens?
2011-01-01 Babakir Mina, M; Ciccozzi, M; Perno, Cf; Ciotti, M
The novel swine-origin H1N1 influenza A virus riddle: is it a domestic bird H1N1-derived virus?
2010-01-01 Babakir Mina, M; Dimonte, S; Ciccozzi, M; Perno, Cf; Ciotti, M
The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes
2009-03-01 Svicher, V; Gori, C; Trignetti, M; Visca, M; Micheli, V; Bernassola, M; Salpini, R; Gubertini, G; Longo, R; Niero, F; CECCHERINI SILBERSTEIN, F; De Sanctis, G; Spanò, A; Cappiello, G; Perno, Cf
The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide A
2005-01-01 Auwerx, J; Rodriguez Barrios, F; CECCHERINI SILBERSTEIN, F; San Felix, A; Velazquez, S; De Clercq, E; Camarasa, M; Perno, Cf; Gago, F; Balzarini, J
The use of human immunodeficiency virus resistance tests in clinical practice
2010-10-01 CECCHERINI SILBERSTEIN, F; Cento, V; Calvez, V; Perno, Cf
The V118I mutation as a marker of advanced HIV infection and disease progression
2007-01-01 Zaccarelli, M; Tozzi, V; Lorenzini, P; Forbici, F; Narciso, P; CECCHERINI SILBERSTEIN, F; Trotta, M; Bertoli, A; Liuzzi, G; Marconi, P; Mosti, S; Perno, Cf; Antinori, A
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs
2005-01-01 Boffito, M; Acosta, E; Burger, D; Fletcher, C; Flexner, C; Garaffo, R; Gatti, G; Kurowski, M; Perno, Cf; Peytavin, G; Regazzi, M; Back, D
Therapeutic strategies towards HIV-1 infection in macrophages
2006-01-01 Perno, Cf; Svicher, V; Schols, D; Pollicita, M; Balzarini, J; Aquaro, S
Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice
2005-01-01 Sarang, Z; Molnar, P; Nemeth, T; Gomba, S; Kardon, T; Melino, G; Cotecchia, S; Fesus, L; Szondy, Z
Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis
2006-01-01 Szondy, Z; Mastroberardino, P; Varadi, J; Farrace, Mg; Nagy, N; Bak, I; Viti, I; Wieckowski, M; Melino, G; Rizzuto, R; Tosaki, A; Fesus, L; Piacentini, M
Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication
2011-10-20 Andrei, G; Lisco, A; Vanpouille, C; Introini, A; Balestra, E; van den Oord, J; Cihlar, T; Perno, Cf; Snoeck, R; Margolis, L; Balzarini, J
Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis
2010-01-01 Lenci, I; Marcuccilli, F; Tisone, G; Di Paolo, D; Tariciotti, L; Ciotti, M; Guenci, T; Perno, Cf; Angelico, M
Transglutaminase 2, a double face enzyme
2017-01-01 Beninati, S; Piacentini, M; Bergamini, C
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel
2017-01-01 Vigano, M; Perno, Cf; Craxi, A
Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev
2009-07-01 Svicher, V; Alteri, C; D'Arrigo, R; Laganà, A; Trignetti, M; Lo Caputo, S; Callegaro, A; Maggiolo, F; Mazzotta, F; Ferro, A; Dimonte, S; Aquaro, S; di Perri, G; Bonora, S; Tommasi, C; Trotta, M; Narciso, P; Antinori, A; Perno, Cf; CECCHERINI SILBERSTEIN, F
Turning regenerative technologies into treatment to repair myocardial injuries
2019-01-01 Carotenuto, F; Teodori, L; Maccari, Am; Delbono, L; Orlando, G; Di Nardo, P
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients
2009-06-01 Santoro, M; Bertoli, A; Lorenzini, P; CECCHERINI SILBERSTEIN, F; Gianotti, N; Mussini, C; Torti, C; Di Perri, G; Barbarini, G; Bini, T; Melzi, S; Caramello, P; Maserati, R; Narciso, P; Micheli, V; Antinori, A; Perno, Cf
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-dic-2011 | The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype | Malet, I; Fourati, S; Charpentier, C; Morand Joubert, L; Armenia, D; Wirden, M; Sayon, S; Van Houtte, M; CECCHERINI SILBERSTEIN, F; Brun Vézinet, F; Perno, Cf; Descamps, D; Capt, A; Calvez, V; Marcelin, A | Articolo su rivista | |
25-apr-2005 | The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs | Auwerx, J; Van Nieuwenhove, J; Rodríguez Barrios, F; de Castro, S; Velázquez, S; CECCHERINI SILBERSTEIN, F; De Clercq, E; Camarasa, M; Perno, Cf; Gago, F; Balzarini, J | Articolo su rivista | |
1-gen-2005 | The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs | Auwerx, J; Van Nieuwenhove, J; Rodriguez Barrios, F; De Castro, S; Velazquez, S; CECCHERINI SILBERSTEIN, F; De Clercq, E; Camarasa, M; Perno, Cf; Gago, F; Balzarini, J | Articolo su rivista | |
1-gen-2011 | The novel KI, WU, MC polyomaviruses: possible human pathogens? | Babakir Mina, M; Ciccozzi, M; Perno, Cf; Ciotti, M | Articolo su rivista | |
1-gen-2010 | The novel swine-origin H1N1 influenza A virus riddle: is it a domestic bird H1N1-derived virus? | Babakir Mina, M; Dimonte, S; Ciccozzi, M; Perno, Cf; Ciotti, M | Articolo su rivista | |
1-mar-2009 | The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes | Svicher, V; Gori, C; Trignetti, M; Visca, M; Micheli, V; Bernassola, M; Salpini, R; Gubertini, G; Longo, R; Niero, F; CECCHERINI SILBERSTEIN, F; De Sanctis, G; Spanò, A; Cappiello, G; Perno, Cf | Articolo su rivista | |
1-gen-2005 | The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide A | Auwerx, J; Rodriguez Barrios, F; CECCHERINI SILBERSTEIN, F; San Felix, A; Velazquez, S; De Clercq, E; Camarasa, M; Perno, Cf; Gago, F; Balzarini, J | Articolo su rivista | |
1-ott-2010 | The use of human immunodeficiency virus resistance tests in clinical practice | CECCHERINI SILBERSTEIN, F; Cento, V; Calvez, V; Perno, Cf | Articolo su rivista | |
1-gen-2007 | The V118I mutation as a marker of advanced HIV infection and disease progression | Zaccarelli, M; Tozzi, V; Lorenzini, P; Forbici, F; Narciso, P; CECCHERINI SILBERSTEIN, F; Trotta, M; Bertoli, A; Liuzzi, G; Marconi, P; Mosti, S; Perno, Cf; Antinori, A | Articolo su rivista | |
1-gen-2005 | Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs | Boffito, M; Acosta, E; Burger, D; Fletcher, C; Flexner, C; Garaffo, R; Gatti, G; Kurowski, M; Perno, Cf; Peytavin, G; Regazzi, M; Back, D | Articolo su rivista | |
1-gen-2006 | Therapeutic strategies towards HIV-1 infection in macrophages | Perno, Cf; Svicher, V; Schols, D; Pollicita, M; Balzarini, J; Aquaro, S | Articolo su rivista | |
1-gen-2005 | Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice | Sarang, Z; Molnar, P; Nemeth, T; Gomba, S; Kardon, T; Melino, G; Cotecchia, S; Fesus, L; Szondy, Z | Articolo su rivista | |
1-gen-2006 | Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis | Szondy, Z; Mastroberardino, P; Varadi, J; Farrace, Mg; Nagy, N; Bak, I; Viti, I; Wieckowski, M; Melino, G; Rizzuto, R; Tosaki, A; Fesus, L; Piacentini, M | Articolo su rivista | |
20-ott-2011 | Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication | Andrei, G; Lisco, A; Vanpouille, C; Introini, A; Balestra, E; van den Oord, J; Cihlar, T; Perno, Cf; Snoeck, R; Margolis, L; Balzarini, J | Articolo su rivista | |
1-gen-2010 | Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis | Lenci, I; Marcuccilli, F; Tisone, G; Di Paolo, D; Tariciotti, L; Ciotti, M; Guenci, T; Perno, Cf; Angelico, M | Articolo su rivista | |
1-gen-2017 | Transglutaminase 2, a double face enzyme | Beninati, S; Piacentini, M; Bergamini, C | Articolo su rivista | |
1-gen-2017 | Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel | Vigano, M; Perno, Cf; Craxi, A | Articolo su rivista | |
1-lug-2009 | Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev | Svicher, V; Alteri, C; D'Arrigo, R; Laganà, A; Trignetti, M; Lo Caputo, S; Callegaro, A; Maggiolo, F; Mazzotta, F; Ferro, A; Dimonte, S; Aquaro, S; di Perri, G; Bonora, S; Tommasi, C; Trotta, M; Narciso, P; Antinori, A; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
1-gen-2019 | Turning regenerative technologies into treatment to repair myocardial injuries | Carotenuto, F; Teodori, L; Maccari, Am; Delbono, L; Orlando, G; Di Nardo, P | Articolo su rivista | |
1-giu-2009 | Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients | Santoro, M; Bertoli, A; Lorenzini, P; CECCHERINI SILBERSTEIN, F; Gianotti, N; Mussini, C; Torti, C; Di Perri, G; Barbarini, G; Bini, T; Melzi, S; Caramello, P; Maserati, R; Narciso, P; Micheli, V; Antinori, A; Perno, Cf | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile